1. Home
  2. IRIX vs RCG Comparison

IRIX vs RCG Comparison

Compare IRIX & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • RCG
  • Stock Information
  • Founded
  • IRIX 1989
  • RCG 1994
  • Country
  • IRIX United States
  • RCG United States
  • Employees
  • IRIX N/A
  • RCG N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RCG Investment Managers
  • Sector
  • IRIX Health Care
  • RCG Finance
  • Exchange
  • IRIX Nasdaq
  • RCG Nasdaq
  • Market Cap
  • IRIX 22.4M
  • RCG 18.2M
  • IPO Year
  • IRIX 1996
  • RCG N/A
  • Fundamental
  • Price
  • IRIX $1.30
  • RCG $2.65
  • Analyst Decision
  • IRIX
  • RCG
  • Analyst Count
  • IRIX 0
  • RCG 0
  • Target Price
  • IRIX N/A
  • RCG N/A
  • AVG Volume (30 Days)
  • IRIX 86.5K
  • RCG 5.9K
  • Earning Date
  • IRIX 11-11-2025
  • RCG 01-01-0001
  • Dividend Yield
  • IRIX N/A
  • RCG 0.98%
  • EPS Growth
  • IRIX N/A
  • RCG N/A
  • EPS
  • IRIX N/A
  • RCG N/A
  • Revenue
  • IRIX $49,744,000.00
  • RCG N/A
  • Revenue This Year
  • IRIX $9.61
  • RCG N/A
  • Revenue Next Year
  • IRIX N/A
  • RCG N/A
  • P/E Ratio
  • IRIX N/A
  • RCG N/A
  • Revenue Growth
  • IRIX 0.09
  • RCG N/A
  • 52 Week Low
  • IRIX $0.78
  • RCG $1.52
  • 52 Week High
  • IRIX $2.04
  • RCG $1.90
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 50.65
  • RCG 53.53
  • Support Level
  • IRIX $1.31
  • RCG $2.56
  • Resistance Level
  • IRIX $1.47
  • RCG $2.71
  • Average True Range (ATR)
  • IRIX 0.07
  • RCG 0.05
  • MACD
  • IRIX -0.01
  • RCG -0.14
  • Stochastic Oscillator
  • IRIX 16.25
  • RCG 97.79

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

Share on Social Networks: